Fresh IPO Signals: Director Buys PBLS Stock—What It Means
A Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
These tips reinforce discipline, such as setting clear categories, automating transfers, and reviewing results monthly.
17,300 articlesA Parabilis Medicines director recently disclosed a substantial stake just after the company’s fresh IPO. This articl...
Bed Bath & Beyond reveals a three-pilot strategy to build a housing platform after purchasing Fathom Holdings. The pl...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
Imagine earning a slice of ownership just by staking crypto. Backpack aims to turn token holders into owners, but the...
Translucent closed a $27 million Series A to expand its AI-native healthcare finance platform, targeting improved rev...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
The chef’s colicchio return tech story highlights how nontraditional investors are finding outsized gains in niche te...
Urban air taxis are moving from concept to reality. This article explores Joby Aviation, the eVTOL pioneer, and wheth...
Axon Enterprise stock popped as investors weighed the company’s expanding product lineup, software growth, and a grow...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
Rocket Lab reports record backlog and margin gains, while Intuitive Machines pursues a transformative acquisition to ...